Dr. Robin Michelle Carson , DO
Obstetrics & Gynecology • Tulsa, OK
5010 E 68th St Ste 200
Tulsa, OK 741363305
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Robin Carson is listed in NPPES under Obstetrics & Gynecology.
-
NPI assigned on April 13, 2006; this date does not establish years in practice.
-
Published CMS data list 16 Original Medicare Part B services in 2019.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019. Published rows only; this is not a quality measure.
-
Published Part B service records, 2019:
- G0101 — Cervical or vaginal cancer screening; pelvic and clinical breast examination: 16 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019. Units differ by code; these are not visits or a measure of quality.
See the full table · Guide: How to read Medicare Part B data
-
Published CMS data list 20 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Estradiol — 20 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table · Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 85% of clinicians listed under Obstetrics & Gynecology in Tulsa, OK (2024, 63 clinicians with data). Median for this group: 63. Middle half: 29 to 120.
Fewer Part D prescriptions than 80% of clinicians listed under Obstetrics & Gynecology in Oklahoma (2024, 229 clinicians with data). Median for this group: 63. Middle half: 26 to 134.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 30 in 2017 to 16 in 2019.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2017–2019.
Practice Location & Contact Primary Location
5010 E 68th St Ste 200
Tulsa, OK 741363305
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Obstetrics & Gynecology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare-allowed amount
About $594 in 2019
The total amount Medicare approved for these services in 2019. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019.
Paid by Medicare
About $594 in 2019
The part of the Medicare-allowed amount that Medicare itself paid in 2019, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019.
30-day fills
48 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,696 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,032.76 across 71 records.
By nature of payment
- Food and Beverage: $1,032.76 across 71 records.
Reporting-company totals (3 largest of 15)
- MAYNE PHARMA COMMERCIAL LLC: $383.37 across 38 records.
- MILLICENT US INC: $171.83 across 9 records.
- Astellas Pharma US Inc: $124.37 across 6 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Carson has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Carson as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Tulsa and Oklahoma
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 85% of clinicians listed under Obstetrics & Gynecology in Tulsa, OK (2024, 63 clinicians with data). Median for this group: 63. Middle half: 29 to 120.
Fewer Part D prescriptions than 80% of clinicians listed under Obstetrics & Gynecology in Oklahoma (2024, 229 clinicians with data). Median for this group: 63. Middle half: 26 to 134.
Part D drug cost
A lower Part D drug cost than 65% of clinicians listed under Obstetrics & Gynecology in Tulsa, OK (2024, 63 clinicians with data). Median for this group: $3,218. Middle half: $1,254 to $7,697.
A lower Part D drug cost than 60% of clinicians listed under Obstetrics & Gynecology in Oklahoma (2024, 229 clinicians with data). Median for this group: $3,225. Middle half: $1,010 to $9,892.
Medicare Part B
Comparisons use 2024 data. The latest CMS data for Dr. Carson are from 2019.
111 active clinicians are listed under Obstetrics & Gynecology with a practice address in Tulsa, OK (439 in Oklahoma).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Tulsa
2.7% of these 111 clinicians have the CMS telehealth indicator.
66.7% of these 111 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 47% from 30 in 2017 to 16 in 2019.
- 2017: 30
- 2018: 24
- 2019: 16
-
Medicare-allowed amount
Medicare-allowed amount decreased 45% from $1,071 in 2017 to $594 in 2019.
- 2017: $1,071
- 2018: $859
- 2019: $594
-
Paid by Medicare
Paid by Medicare decreased 45% from $1,071 in 2017 to $594 in 2019.
- 2017: $1,071
- 2018: $859
- 2019: $594
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 29% from 28 in 2018 to 20 in 2024.
- 2018: 28
- 2019: 56
- 2020: 30
- 2023: 19
- 2024: 20
-
30-day fills
30-day fills varied from year to year: 47 in 2018 and 48 in 2024.
- 2018: 47
- 2019: 86
- 2020: 62
- 2023: 31
- 2024: 48
-
Part D drug cost
Part D drug cost decreased 77% from $7,235 in 2018 to $1,696 in 2024.
- 2018: $7,235
- 2019: $8,520
- 2020: $8,878
- 2023: $2,557
- 2024: $1,696
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 43% from $1,802.36 in 2021 to $1,032.76 in 2025.
- 2021: $1,802.36
- 2022: $1,311.30
- 2023: $1,369.85
- 2024: $1,075.79
- 2025: $1,032.76
Sources: CMS Medicare Physician & Other Practitioners (2019), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 71 records totaling $1,032.76.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| CooperSurgical, Inc. |
Food and Beverage
In-kind items and services
|
Paragard T 380A | General | $29.35 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Veozah | General | $26.26 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
ABRYSVO | General | $25.79 |
| Dexcom, Inc. |
Food and Beverage
In-kind items and services
|
Dexcom G6 Transmitter | General | $24.83 |
| Exeltis, USA Inc. |
Food and Beverage
In-kind items and services
|
SLYND | General | $24.32 |
| Sage Therapeutics, LLC |
Food and Beverage
In-kind items and services
|
ZURZUVAE | General | $23.19 |
| MILLICENT US INC |
Food and Beverage
In-kind items and services
|
FEMRING | General | $23.05 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
MYFEMBREE | General | $22.87 |
| MILLICENT US INC |
Food and Beverage
In-kind items and services
|
FEMRING | General | $22.80 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Lynkuet | General | $22.69 |
| Exeltis, USA Inc. |
Food and Beverage
In-kind items and services
|
SLYND | General | $22.02 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Veozah | General | $22.00 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Veozah | General | $21.32 |
| MILLICENT US INC |
Food and Beverage
In-kind items and services
|
FEMLYV | General | $21.20 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Veozah | General | $20.88 |
| MILLICENT US INC |
Food and Beverage
In-kind items and services
|
FEMLYV | General | $20.24 |
| MILLICENT US INC |
Food and Beverage
In-kind items and services
|
FEMLYV | General | $20.13 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Veozah | General | $20.13 |
| MILLICENT US INC |
Food and Beverage
In-kind items and services
|
FEMLYV | General | $19.01 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
MYFEMBREE | General | $18.53 |
| HOLOGIC INC |
Food and Beverage
In-kind items and services
|
APTIMA | General | $17.65 |
| Sage Therapeutics, LLC |
Food and Beverage
In-kind items and services
|
ZURZUVAE | General | $17.51 |
| Supernus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
Qelbree | General | $17.51 |
| Intra-Sana Laboratories |
Food and Beverage
In-kind items and services
|
GLYCATE | General | $16.93 |
| Organon LLC |
Food and Beverage
In-kind items and services
|
NEXPLANON | General | $16.32 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
G0101
Cervical or vaginal cancer screening; pelvic and clinical breast examination
|
16 | 16 | $82.00 | $37.11 |
Source: CMS Part B by Provider and Service, 2019; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Estradiol | Estradiol | 20 | 1,439 | $1,696.21 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207V00000X
An obstetrician/gynecologist possesses special knowledge, skills and professional capability in the medical and surgical care of the female reproductive system and associated disorders. This physician serves as a consultant to other physicians and as a primary physician for women.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OBSTETRICS/GYNECOLOGY
I20040102000822
OK
6103725767
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Obstetrics & Gynecology
Doctor of Osteopathic Medicine (D.O.)
Obstetrics & Gynecology
Doctor of Osteopathic Medicine (D.O.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 5010 E 68TH ST STE 200, TULSA, OK 741363305 (Tel: 9189602827)
Registered at 5010 E 68TH ST STE 200, TULSA, OK 741363305 (Tel: 9189602827)
NPI status registered as active in NPPES database
Registered at 8803 S 101ST EAST AVE, STE 245, TULSA, OK 741335726 (Tel: 9182502033)
Registered at 8803 S 101ST EAST AVE, STE 245, TULSA, OK 741335726 (Tel: 9182502033)
Recorded as ROBIN CARSON, DO
Obstetrics & Gynecology (license number reported to NPPES: OK 3652)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Obstetrics & Gynecology Specialists in Tulsa
- Dr. Bryan Roehl, DO
- Dr. John Beal, DO
- Dr. Amanda Whytal, DO
- Dr. Timmeni Stevens, DO
- Dr. Grant Cox, MD
- Dr. Stacy Noland, DO
Mailing Address
5010 E 68th St Ste 200
Tulsa, OK 741363305
Phone: 9189602827